UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Bogart Wealth LLC

Bogart Wealth LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 24.6% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,802 shares of the healthcare conglomerate's stock after selling 2,867 shares during the quarter. Bogart Wealth LLC's holdings in UnitedHealth Group were worth $4,610,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $26,000. Hurley Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $28,000. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $30,000. Kapitalo Investimentos Ltda purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $41,000. Finally, Copia Wealth Management purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $42,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Insiders Place Their Bets

In other UnitedHealth Group news, CFO John F. Rex acquired 17,175 shares of the firm's stock in a transaction on Friday, May 16th. The stock was purchased at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the transaction, the chief financial officer owned 203,796 shares of the company's stock, valued at $59,329,091.52. The trade was a 9.20% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the firm's stock in a transaction on Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the transaction, the director directly owned 6,033 shares in the company, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock worth $31,607,768 over the last three months. Company insiders own 0.28% of the company's stock.

Analyst Ratings Changes

UNH has been the subject of a number of analyst reports. Wells Fargo & Company restated an "overweight" rating on shares of UnitedHealth Group in a report on Friday, June 6th. Raymond James Financial cut UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. Robert W. Baird cut UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 target price for the company. in a research note on Wednesday, June 11th. TD Securities reiterated a "hold" rating and set a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research note on Wednesday, May 14th. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $415.00.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $303.81 on Monday. The firm has a market capitalization of $275.60 billion, a PE ratio of 12.72, a P/E/G ratio of 1.46 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The business's fifty day moving average price is $314.52 and its two-hundred day moving average price is $439.94.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the business posted $6.91 earnings per share. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a $2.21 dividend. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.91%. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.